vimarsana.com
Home
Live Updates
Telo Genomics Corp.: Telo Genomics Announces Successful Vali
Telo Genomics Corp.: Telo Genomics Announces Successful Vali
Telo Genomics Corp.: Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma
Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") announces that it has completed the validation of a suite of proprietary automation
Related Keywords
United States ,
Canada ,
Caen ,
Basse Normandie ,
France ,
Toronto ,
Ontario ,
Canadian ,
Hugh Rogers ,
Sherif Louis ,
Mars Centre ,
Newsfile Corp ,
Telo Genomics Corp ,
Francois Baclesse Cancer Center ,
Company Science Technology Committee ,
Venture Exchange ,
Regulation Services Provider ,
Technology Committee ,
Mayo Clinic ,
South Tower ,
Atelo ,
Genomics ,
Orp ,
Nnounces ,
Uccessful ,
Validation ,
Roprietary ,
Utomation ,
Tools ,
Smoldering ,
Multiple ,
Myeloma ,